|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu X, Qiu H, Kong P, Zhou Z and Sun X:
Gastric cancer, nutritional status, and outcome. Onco Targets Ther.
10:2107–2114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maleki SS and Röcken C: Chromosomal
instability in gastric cancer biology. Neoplasia. 19:412–420. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han W, Lou Y, Tang J, Zhang Y, Chen Y, Li
Y, Gu W, Huang J, Gui L, Tang Y, et al: Molecular cloning and
characterization of chemokine-like factor 1 (CKLF1), a novel human
cytokine with unique structure and potential chemotactic activity.
Biochem J. 357:127–135. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han W, Ding P, Xu M, Wang L, Rui M, Shi S,
Liu Y, Zheng Y, Chen Y, Yang T, et al: Identification of eight
genes encoding chemokine-like factor superfamily members 1-8
(CKLFSF1-8) by in silico cloning and experimental validation.
Genomics. 81:609–617. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie J, Yuan Y, Liu Z, Xiao Y, Zhang X, Qin
C, Sheng Z, Xu T and Wang X: CMTM3 is frequently reduced in clear
cell renal cell carcinoma and exhibits tumor suppressor activities.
Clin Transl Oncol. 16:402–409. 2014. View Article : Google Scholar
|
|
8
|
Shao L, Guo X, Plate M, Li T, Wang Y, Ma D
and Han W: CMTM5-v1 induces apoptosis in cervical carcinoma cells.
Biochem Biophys Res Commun. 379:866–871. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu B, Su Y, Li T, Yuan W, Mo X, Li H, He
Q, Ma D and Han W: CMTM7 knockdown increases tumorigenicity of
human non-small cell lung cancer cells and EGFR-AKT signaling by
reducing Rab5 activation. Oncotarget. 6:41092–41107. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang W, Mendoza MC, Pei X, Ilter D,
Mahoney SJ, Zhang Y, Ma D, Blenis J and Wang Y: Down-regulation of
CMTM8 induces epithelial-to-mesenchymal transition-like changes via
c-MET/extracellular signal-regulated kinase (ERK) signaling. J Biol
Chem. 287:11850–11858. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yuan W, Li T, Mo X, Wang X, Liu B, Wang W,
Su Y, Xu L and Han W: Knockdown of CMTM3 promotes metastasis of
gastric cancer via the STAT3/Twist1/EMT signaling pathway.
Oncotarget. 7:29507–29519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H,
Li H, Shu XS, Li H, Liu W, et al: CMTM3, located at the critical
tumor suppressor locus 16q22.1, is silenced by CpG methylation in
carcinomas and inhibits tumor cell growth through inducing
apoptosis. Cancer Res. 69:5194–5201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Su Y, Lin Y, Zhang L, Liu B, Yuan W, Mo X,
Wang X, Li H, Xing X, Cheng X, et al: CMTM3 inhibits cell migration
and invasion and correlates with favorable prognosis in gastric
cancer. Cancer Sci. 105:26–34. 2014. View Article : Google Scholar
|
|
14
|
Catela Ivkovic T, Voss G, Cornella H and
Ceder Y: microRNAs as cancer therapeutics: A step closer to
clinical application. Cancer Lett. 407:113–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng Q, Chen C, Guan H, Kang W and Yu C:
Prognostic role of microRNAs in human gastrointestinal cancer: A
systematic review and meta-analysis. Oncotarget. 8:46611–46623.
2017.PubMed/NCBI
|
|
16
|
Hua K, Jin J, Zhao J, Song J, Song H, Li
D, Maskey N, Zhao B, Wu C, Xu H, et al: miR-135b, upregulated in
breast cancer, promotes cell growth and disrupts the cell cycle by
regulating LATS2. Int J Oncol. 48:1997–2006. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xue Y, Ni T, Jiang Y and Li Y: Long
noncoding RNA GAS5 inhibits tumorigenesis and enhances
radiosensitivity by suppressing miR-135b expression in non-small
cell lung cancer. Oncol Res. 25:1305–1316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang N, Tao L, Zhong H, Zhao S, Yu Y, Yu
B, Chen X, Gao J and Wang R: miR-135b inhibits tumour metastasis in
prostate cancer by targeting STAT6. Oncol Lett. 11:543–550.
2016.PubMed/NCBI
|
|
19
|
Su W, Mo Y, Wu F, Guo K, Li J, Luo Y, Ye
H, Guo H, Li D and Yang Z: miR-135b reverses chemoresistance of
non-small cell lung cancer cells by downregulation of FZD1. Biomed
Pharmacother. 84:123–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li P, Fan JB, Gao Y, Zhang M, Zhang L,
Yang N and Zhao X: miR-135b-5p inhibits LPS-induced TNFα production
via silencing AMPK phosphatase Ppm1e. Oncotarget. 7:77978–77986.
2016.PubMed/NCBI
|
|
21
|
Li Z, Li X, Xu L, Tao Y, Yang C, Chen X,
Fang F, Wu Y, Ding X, Zhao H, et al: Inhibition of neuroblastoma
proliferation by PF-3758309, a small-molecule inhibitor that
targets p21-activated kinase 4. Oncol Rep. 38:2705–2716.
2017.PubMed/NCBI
|
|
22
|
Miles DC, van den Bergen JA, Sinclair AH
and Western PS: Regulation of the female mouse germ cell cycle
during entry into meiosis. Cell Cycle. 9:408–418. 2010. View Article : Google Scholar
|
|
23
|
Di Meo S, Airoldi I, Sorrentino C, Zorzoli
A, Esposito S and Di Carlo E: Interleukin-30 expression in prostate
cancer and its draining lymph nodes correlates with advanced grade
and stage. Clin Cancer Res. 20:585–594. 2014. View Article : Google Scholar
|
|
24
|
Li Z, Xie J, Wu J, Li W, Nie L, Sun X,
Tang A, Li X, Liu R, Mei H, et al: CMTM3 inhibits human testicular
cancer cell growth through inducing cell-cycle arrest and
apoptosis. PLoS One. 9:e889652014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Delic S, Thuy A, Schulze M, Proescholdt
MA, Dietrich P, Bosserhoff AK and Riemenschneider MJ: Systematic
investigation of CMTM family genes suggests relevance to
glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.
Genes Chromosomes Cancer. 54:433–443. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Chen C, Bi X, Zhou C, Huang T, Ni C,
Yang P, Chen S, Ye M and Duan S: DNA methylation of CMTM3, SSTR2,
and MDFI genes in colorectal cancer. Gene. 630:1–7. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cho CJ, Myung SJ and Chang S: ADAR1 and
microRNA; A hidden crosstalk in cancer. Int J Mol Sci. 18:E7992017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Forrest ME and Khalil AM: Review:
Regulation of the cancer epigenome by long non-coding RNAs. Cancer
Lett. 407:106–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lulli V, Buccarelli M, Martini M, Signore
M, Biffoni M, Giannetti S, Morgante L, Marziali G, Ilari R,
Pagliuca A, et al: miR-135b suppresses tumorigenesis in
glioblastoma stem-like cells impairing proliferation, migration and
self-renewal. Oncotarget. 6:37241–37256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li J, Liang H, Bai M, Ning T, Wang C, Fan
Q, Wang Y, Fu Z, Wang N, Liu R, et al: miR-135b promotes receptor
II (TGFBR2) in colorectal cancer. PLoS One. 10:e01301942015.
View Article : Google Scholar
|
|
31
|
Li Y, Xu D, Bao C, Zhang Y, Chen D, Zhao
F, Ding J, Liang L, Wang Q, Liu L, et al: MicroRNA-135b, a HSF1
target, promotes tumor invasion and metastasis by regulating RECK
and EVI5 in hepatocellular carcinoma. Oncotarget. 6:2421–2433.
2015. View Article : Google Scholar :
|
|
32
|
Vidal AF, Cruz AM, Magalhães L, Pereira
AL, Anaissi AK, Alves NC, Albuquerque PJ, Burbano RM, Demachki S
and Ribeiro-dos-Santos Â: hsa-miR-29c and hsa-miR-135b differential
expression as potential biomarker of gastric carcinogenesis. World
J Gastroenterol. 22:2060–2070. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Suzuki H, Maruyama R, Yamamoto E and Kai
M: Epigenetic alteration and microRNA dysregulation in cancer.
Front Genet. 4:2582013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ando T, Yoshida T, Enomoto S, Asada K,
Tatematsu M, Ichinose M, Sugiyama T and Ushijima T: DNA methylation
of microRNA genes in gastric mucosae of gastric cancer patients:
Its possible involvement in the formation of epigenetic field
defect. Int J Cancer. 124:2367–2374. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Zhao X, Fiskus W, Lin J, Lwin T,
Rao R, Zhang Y, Chan JC, Fu K, Marquez VE, et al: Coordinated
silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic
target of histone modification in aggressive B-Cell lymphomas.
Cancer Cell. 22:506–523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan H, Choi AJ, Lee BH and Ting AH:
Identification and functional analysis of epigenetically silenced
microRNAs in colorectal cancer cells. PLoS One. 6:e206282011.
View Article : Google Scholar : PubMed/NCBI
|
